Long P. Qin

Lanzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Erratum to "Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer".

Erratum to "Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer".

Journal: Research (Washington, D.C.)
Published: July 22, 2026

Targeting MEST using cobicistat as a therapeutic strategy for gastric cancer through suppressing NF-κB signaling.

Targeting MEST using cobicistat as a therapeutic strategy for gastric cancer through suppressing NF-κB signaling.

Journal: Frontiers in oncology
Published: June 06, 2026

Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response.

Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response.

Journal: Journal for immunotherapy of cancer
Published: May 21, 2026

Fusobacterium varium Exacerbates Neutrophil-driven Intestinal Inflammation Associated with Succinate-SUCNR1-NF-κB Signaling.

Fusobacterium varium Exacerbates Neutrophil-driven Intestinal Inflammation Associated with Succinate-SUCNR1-NF-κB Signaling.

Journal: Inflammation
Published: March 15, 2026

USP20 promotes CD8+ T cell exhaustion and impairs KRASG12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.

USP20 promotes CD8+ T cell exhaustion and impairs KRASG12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.

Journal: Gut
Published: January 27, 2026

Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy.

Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy.

Journal: Cancer research
Published: December 19, 2025

NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions.

NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions.

Journal: Frontiers in immunology
Published: December 09, 2025

The role of RARG in solid tumor progression and therapeutic potential.

The role of RARG in solid tumor progression and therapeutic potential.

Journal: Discover oncology
Published: November 18, 2025

RARG promotes gastric cancer progression by activating PMEPA1 transcription and Wnt/β-catenin signalling.

RARG promotes gastric cancer progression by activating PMEPA1 transcription and Wnt/β-catenin signalling.

Journal: Cellular signalling
Published: November 18, 2025

Targeted DDR1 Treatment Strategy Enhances PD-1 Immunotherapy Efficacy against Gastric Cancer.

Targeted DDR1 Treatment Strategy Enhances PD-1 Immunotherapy Efficacy against Gastric Cancer.

Journal: Journal of medicinal chemistry
Published: October 27, 2025

A Real-Time Online Nomogram Integrating Systemic Inflammatory Response Index and Lactate Dehydrogenase to Predict Pathological Response in Gastric Cancer Patients Receiving Neoadjuvant Chemoimmunotherapy.

A Real-Time Online Nomogram Integrating Systemic Inflammatory Response Index and Lactate Dehydrogenase to Predict Pathological Response in Gastric Cancer Patients Receiving Neoadjuvant Chemoimmunotherapy.

Journal: Cancer management and research
Published: August 08, 2025

UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer.

UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 06, 2025
Showing 1-12 of 38

Last Updated: 09/26/2026